Official 2024 U.S. DOL Form 5500 summary for Teva Pharmaceuticals USA, INC. (Teva Pharmaceuticals Retirement Savings Plan · EIN 22-1734359 · PN 004): $2.33B net assets, 5,037 active participants, and $4.04 per $10,000 (4.04 bps).
| Plan Sponsor | Teva Pharmaceuticals USA, INC. |
|---|---|
| Filing Identifier | Teva Pharmaceuticals Retirement Savings Plan · EIN 22-1734359 · PN 004 |
| Plan Category & State | 401(k) Defined Contribution (NJ) |
| Asset-Size Peer Cohort | >$1B |
| Plan Net Assets (2024) | $2.33B |
| Active Participants | 5,037 |
| Direct Admin Fee Rate | $4.04 per $10,000 (4.04 bps) |
| Cohort Peer Median | $4.40 per $10,000 (4.40 bps) |
| Primary Recordkeeper / Provider | Fidelity Investments |
| Schedule H Line 4a Remittance | Timely Employer Remittance (0 reported on Line 4a) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI
Verified federal filings reconciled for Teva Pharmaceuticals across sibling Meru AI platforms.